Jules Tchatchueng

Jules Tchatchueng , Docteur

Senior Researcher

Jules Brice Tchatchueng is a researcher at the Centre Pasteur du Cameroun and an adjunct lecturer at the University of Yaoundé I. Since 2012, I have completed my PhD in biostatistics at the University of Montpellier II France and the University of Yaoundé I, Cameroon. My research interests are in the areas of spatio-temporal modelling, modelling of longitudinal data, non-inferiority test for longitudinal data with variable margin, data acquisition and integration tools. For over ten years, I have conducted several projects on public health programme evaluation, antiretroviral treatment efficacy assessment for HIV patients, and epidemiological surveillance of infectious diseases.

Research projects

1

Development of an automated rapid diagnostic test reader for COVID-19 mass testing

  • Chef de projet: Jules Brice Tchatchueng Mbougua, Centre Pasteur du Cameroun / UMMISCO, Cameroun
  • Durée du projet: 24 Months
  • Date de début: February 2021
2

New Observation and Control Issues Motivated by Epidemiology (NOCIME)

  • ANR 2023: INRIA, INRAE et IRD 
  • Participants UMMISCO: G. Sallet et B. Cazelles (Correspondant IRD et Responsable WP1)
  • Durée du projet: 36 months
  • Date début du projet: Janvier 2024
  • Budget total: 350K€

3

Insights into amebiasis using a human 3D-intestinal model (ANR-14-IFEC-0001-02)

his project is a part of the international Infect-Era program, AMOEBAC: Entamoeba histolytica-bacterium interaction and the role of this interaction in intestinal pathogenesis (http://www.infect-era.eu/2nd-call-2014)

The aim of this investigation is to understand the induced changes in physiology, metabolism, and gene expression of Entamoeba histolytica following its interaction with enteric bacteria and during intestine invasion. We take advantage of human tissue-like models to study amoebic pathogenesis combining imaging, image analysis and Omics approaches. The three-dimensional tissue model consists of a human cells system composed of fibrillar collagen I matrix, intestinal cells (epithelial, fibroblasts and goblets) and macrophages. Using this model, we determine the rate of amebic invasiveness using two-photon laser scanning fluorescence microscopy, assess the immune response using ELISA, investigate human gene expression by RNA sequencing and discover the secretome using proteomics and HPLC-MS/MS.

4

Call Emulate 2020

In the human colon, mucus protects the underlying epithelium from pathogens. During infection, pathogens and resident microbiota compete for nutritional metabolites and therefore changes may alter the equilibrium in the colon ecosystem contributing to the susceptibility to infection. Around 50–60 % of the population in developing countries might be harboring E. histolytica in the outer mucus layer in an asymptomatic manner. Only ∼20% of the cases develop intestinal amoebiasis and thus under conditions not fully understood. E. histolytica overcomes the protective mucus layer using a combination of mucinase/glycosidase and cysteine proteases. Actually, publications of study on the field and in vitro suggest that the outcome of amoebiasis may be influenced by the composition of the gut microbiome.

– In this project, we aim at studying the impact of the mucus colonised with different commensal bacteria (in collaboration with H. Tun) on the mechanic of the epithelium and on E. histolytica behaviour using human organoid-derived colonic epithelial cells (in collaboration with G. Nigro) cultured in an organ-on-a-chip microfluidic device (in collaboration with the microfluidics plateform. S. Gobaa and H. Mary).
– By live imaging and quantitative image we will measure the stress maps within the tissue using an integrated framework to analyze cell mechanics and we will qualify E. histolytica behavior.

Publications

Nov 2024
Arsène Brunelle Sandie, Jules Brice Tchatchueng Mbougua, Anne Esther Njom Nlend, Sokhna Thiam, Betrand Fesuh Nono, Ndèye Awa Fall, Diarra Bousso Senghor, El Hadji Malick Sylla & Cheikh Mbacké Faye

Hot-spots of HIV infection in Cameroon: a spatial analysis based on Demographic and Health Surveys data

BMC Infectious Diseases
Mar 2023
Jules Brice Tchatchueng-Mbougua Loique Landry Messanga Essengue Francis Jaudel Septoh Yuya Vanessa Kamtchogom Achta Hamadou Serge Alain Sadeuh-Mbah Paul Alain Tagnouokam-Ngoupo Maurice Tchuente Richard Njouom Sara Eyangoh Mathurin Cyrille Tejiokem

Improving the management and security of COVID 19 diagnostic test data with a digital platform in resource-limited settings: The case of PlaCARD in Cameroon

PLOS Digital Health Published on 05 Oct 2022
Nov 2022

Semi-Supervised Segmentation with Topological Penalization for Quantifying Retinal Degeneration in Histological Sections

2024 IEEE International Symposium on Biomedical Imaging (ISBI) - 30 mai 2024
Nov 2020
Manuela C Aguirre-Botero 1, Lawrence T Wang 2, Pauline Formaglio 1, Eduardo Aliprandini 1, Jean-Michel Thiberge 1, Arne Schön 3, Yevel Flores-Garcia 4, Shamika Mathis-Torres 4, Barbara J Flynn 2, Lais da Silva Pereira 2, Yann Le Duff 5, Mathew Hurley 5, Adéla Nacer 6, Paul W Bowyer 6, Fidel Zavala 4, Azza H Idris 2, Joseph R Francica 2, Robert A Seder 7, Rogerio Amino 8

Cytotoxicity of human antibodies targeting the circumsporozoite protein is amplified by 3D substrate and correlates with protection.,

Cell Rep 2023 Jul; 42(7): 112681.
May 2018
Joseph Kamgno, Jules B. Tchatchueng-Mbougua, Hugues C. Nana-Djeunga, Lynda Esso, Honorat G. Zouré, Charles D. Mackenzie & Michel Boussinesq

Community-based door to door census of suspected people living with epilepsy: empowering community drug distributors to improve the provision of care to rural communities in Cameroon

BMC Public Health
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.